Ms. Dawn E. Merth-johnson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 N Wisconsin Ave, Muscoda, WI 53573 Phone: 608-739-3186 |
News Archive
Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide.
U.S. medical schools have made significant progress to strengthen their management of clinical conflicts of interest, but a new study demonstrates that most schools still lag behind national standards. The Institute on Medicine as a Profession study, which compared changes in schools' policies in a dozen areas from 2008 to 2011, reveals that institutions are racing from the bottom to the middle, not to the top.
Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection-by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.
The BIOMARGIN (BIOMArkers of Renal Graft INjuries in kidney allograft recipients) research project, coordinated by INSERM, has just received financing from the "health" seventh framework programme of the European Commission to the tune of 6 million euros for a four-year period.
Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were opened with balloon angioplasty and stents in a study presented at the American College of Cardiology's 64th Annual Scientific Session.
› Verified 7 days ago